DiA Imaging Analysis

Company Overview

Snapshot

Founded in October 2009 by Arnon Toussia Cohen, Noah Liel - Cohen, Hila Goldman Aslan, and Hugo Guterman, DiA Imaging Analysis operates with 11–50 employees. The company secured its last disclosed funding of $14 million in August 2021 and was acquired by Philips in May 2023.

Business overview

DiA Imaging Analysis develops AI-powered ultrasound analysis software designed to address challenges in image capture and accurate analysis for medical professionals. Its technology leverages advanced pattern recognition, deep learning, and machine learning algorithms to automate the detection of image borders and identification of motion, mimicking human visual analysis. The company's flagship product, LVivo Seamless, is an AI-based solution that preselects and instantly analyzes optimal apical cardiac ultrasound views, providing measurements for Strain, EF, and Right Ventricle Size and Function. DiA's LVivo Toolbox, which is FDA cleared, CE marked, and ISO certified, is utilized by thousands of users globally, serving the digital healthcare, medical decision support, and digital medical diagnostics sectors.

Strategic signal

The acquisition of DiA Imaging Analysis by Philips in May 2023 represents a significant strategic consolidation within the health tech sector. This move signals Philips' commitment to enhancing its ultrasound portfolio with advanced AI capabilities, integrating DiA's proven technology into a larger healthcare ecosystem. For investors, this highlights the increasing value placed on AI-driven diagnostic tools and the potential for successful exits in the medical imaging analysis market.

Company Intelligence Q&A

What was the most significant corporate event for DiA Imaging Analysis recently?

DiA Imaging Analysis was acquired by Philips in May 2023, marking a major exit for the company in the health tech sector.

When did DiA Imaging Analysis receive its last disclosed funding?

DiA Imaging Analysis received $14 million in funding in August 2021. Investors included Connecticut Innovations and ICON Community Fund.

What was a key partnership announced by DiA Imaging Analysis in 2021?

In March 2021, DiA Imaging Analysis partnered with Philips to enhance ultrasound with AI-based image quantification, a collaboration that preceded its eventual acquisition by Philips.

Has DiA Imaging Analysis received any regulatory clearances for its technology?

Yes, DiA Imaging Analysis was granted FDA clearance for its cardiac ultrasound AI auto views selection in October 2020, and secured FDA clearance for new AI-powered software assisting ultrasound users to capture high-quality images in February 2023.

What was DiA Imaging Analysis's involvement in the fight against COVID-19?

In May 2020, DiA Imaging Analysis received a grant from the Israel Innovation Authority to accelerate global access to its AI ultrasound solutions to aid in the fight against COVID-19, and secured FDA clearance and CE Mark for additional AI-based ultrasound analysis solutions for use on the COVID-19 frontlines in June 2020.